FDA Warns About Possible Tainted Drugs and Supplements
The U.S. Food and Drug Administration (FDA) has issued a warning about potential contamination of several brands of drugs and dietary supplements. Due to possible contamination with Burkholderia cepacia (B. cepacia) bacteria, the agency advised health care professionals and consumers to avoid using any liquid drug or supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals, and Leader Brands.
According to FDA Commissioner Scott Gottlieb, M.D., the products were distributed nationwide to retailers, health care facilities, and pharmacies, and sold online. They include liquid stool softeners (docusate sodium drugs), as well as liquid vitamin D drops and multivitamins marketed for children and infants.
The Centers for Disease Control and Prevention (CDC) reports that B. cepacia poses a serious threat to people who are hospitalized -- especially those in critical condition – and those with chronic lung diseases and weakened immune systems. Symptoms of infection vary from none at all to severe respiratory problems. B. cepacia can spread from person-to-person by direct contact and is often resistant to common antibiotics.